- World rank, all time
- #41,672 of 42,892
- Rank in Hungary
- #181 of 189
- Research works
- 253 ▲ 106% vs 2013–17
- Citations
- 437 1.7 per fractional work
- Top-10% rate
- 3.7% record average 16.5%
- Open access
- 18% world 28%
What is Országos Reumatológiai és Fizioterápiás Intézet known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #17,300 of 17,978 | 0.4% | 181 | |
| Health SciencesDomain | #19,860 of 20,462 | 0.3% | 188 |
Each strip is that field’s whole ranked pool, with the notch where Országos Reumatológiai és Fizioterápiás Intézet sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 5.9×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 5.9×
- Medicine 3.3×
- Veterinary 2.5×
- Biochemistry, Genetics and Molecular Biology 1.9×
- Social Sciences 1.3×
- Dentistry 1.1×
- Health Professions 0.9×
- Environmental Science 0.3×
- Earth and Planetary Sciences 0.2×
- Economics, Econometrics and Finance 0.2×
- Neuroscience 0.2×
- Computer Science 0.1×
- Engineering 0.1×
- Agricultural and Biological Sciences 0.0×
- Immunology and Microbiology 0.0×
Who are the top researchers at Országos Reumatológiai és Fizioterápiás Intézet?
Ranked on the composite score, E Nemesánszky lead among researchers whose main affiliation is Országos Reumatológiai és Fizioterápiás Intézet.
- 1 E Nemesánszky Hungary · #1,518,966 worldwide 7 citations · 23 works
Which keywords describe research at Országos Reumatológiai és Fizioterápiás Intézet?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Economic Development, Policy, Sustainability, Globalization, Minimal Residual Disease, Radiotherapy, Diagnosis Criteria and International Myeloma Working Group.
- Treatment Response
- Molecular Profiling
- Immunotherapy
- Gene Expression Profiling
- Cancer of Unknown Primary
- Survival Analysis
- Epidemiology
- Gene Expression
- Human Papillomavirus
- Squamous Cell Carcinoma
- Prognostic Factors
- International Myeloma Working Group
- Radiotherapy
- Policy
- Globalization
- Sustainability
- Economic Development
- Minimal Residual Disease
- Diagnosis Criteria
- Chemotherapy
- Metastasis
- Survival
- Oropharyngeal Cancer
- Clinical Management
- Treatment
- Breast Tumours
- Clinical Practice Guidelines
- Geodesy
- Map Projections
- Tissue of Origin
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 30 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 30 words, with their numbers
- Sustainability4▲ 5.6×3 topics
- Globalization4▲ 6.3×2 topics
- Economic Development4▲ 15×1 topic
- Policy4▲ 55×1 topic
- Minimal Residual Disease3▲ 149×2 topics
- Radiotherapy3▲ 24×5 topics
- Diagnosis Criteria3▲ 259×1 topic
- International Myeloma Working Group3▲ 259×1 topic
- Chemotherapy2▲ 9.0×3 topics
- Prognostic Factors2▲ 14×6 topics
- Metastasis2▲ 15×3 topics
- Squamous Cell Carcinoma2▲ 57×3 topics
- Survival2▲ 36×3 topics
- Human Papillomavirus1▲ 37×1 topic
- Oropharyngeal Cancer1▲ 89×1 topic
- Gene Expression1▲ 6.8×2 topics
- Clinical Management1▲ 21×2 topics
- Epidemiology1◆ 0.97×10 topics
- Treatment1▲ 3.0×7 topics
- Survival Analysis1▲ 12×2 topics
- Breast Tumours1▲ 67×1 topic
- Cancer of Unknown Primary1▲ 113×1 topic
- Clinical Practice Guidelines1▲ 5.8×2 topics
- Gene Expression Profiling1▲ 39×2 topics
- Geodesy1▲ 216×1 topic
- Immunotherapy1▲ 4.5×6 topics
- Map Projections1▲ 522×1 topic
- Molecular Profiling1▲ 32×2 topics
- Tissue of Origin1▲ 113×1 topic
- Treatment Response1▲ 67×1 topic
Which research topics does Országos Reumatológiai és Fizioterápiás Intézet publish most on?
By volume in 2022–2025: Hungarian Social, Economic and Educational Studies, Multiple Myeloma Research and Treatments, Head and Neck Cancer Studies and Cancer Diagnosis and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Hungarian Social, Economic and Educational Studies Geography, Planning and Development 4 works
- 2 Multiple Myeloma Research and Treatments Hematology 3 works
- 3 Head and Neck Cancer Studies Otorhinolaryngology 1 works
- 4 Cancer Diagnosis and Treatment Oncology 1 works
- 5 Historical Geography and Cartography Geography, Planning and Development 1 works
- 6 Breast Cancer Treatment Studies Cancer Research 1 works
- 7 Acute Myeloid Leukemia Research Hematology 1 works
- 8 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 1 works
- 9 Chronic Lymphocytic Leukemia Research Genetics 1 works
- 10 Chronic Myeloid Leukemia Treatments Hematology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Országos Reumatológiai és Fizioterápiás Intézet's research output changed?
Output in 2018–2022 was 106% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Budapest
- Eötvös Loránd University
- Hungarian Academy of Sciences
- Semmelweis University
- Budapest University of Technology and Economics
- Corvinus University of Budapest
- Obuda University
- Ludovika University of Public Service
- University of Veterinary Medicine
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.